Detalhe da pesquisa
1.
Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells.
Blood
; 141(14): 1718-1723, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36563336
2.
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
Proc Natl Acad Sci U S A
; 118(49)2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845035
3.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
4.
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation.
N Engl J Med
; 379(24): 2330-2341, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30380364
5.
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.
Blood
; 129(19): 2680-2692, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292947
6.
Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells.
Blood
; 129(21): 2939-2949, 2017 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28400375
7.
Enhanced in utero allogeneic engraftment in mice after mobilizing fetal HSCs by α4ß1/7 inhibition.
Blood
; 128(20): 2457-2461, 2016 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27650329
8.
Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform.
Blood
; 127(1): 122-31, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26531164
9.
Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated.
Biol Blood Marrow Transplant
; 22(10): 1851-1860, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27318038
10.
[(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility.
Mol Ther
; 23(6): 1110-1122, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25807290
11.
CiTE antibody for AML.
Blood
; 132(23): 2425-2427, 2018 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523124
12.
Ixazomib, an oral proteasome inhibitor, induces rapid mobilization of hematopoietic progenitor cells in mice.
Blood
; 131(23): 2594-2596, 2018 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695518
13.
Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia.
Haematologica
; 105(8): e404-e407, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753931
14.
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.
Blood
; 119(17): 3917-24, 2012 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22308295
15.
Streptavidin-drug conjugates streamline optimization of antibody-based conditioning for hematopoietic stem cell transplantation.
bioRxiv
; 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405731
16.
Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager.
PLoS One
; 19(5): e0300174, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696390
17.
Blinatumomab consolidation post-autologous stem cell transplantation in patients with diffuse large B-cell lymphoma.
Blood Adv
; 8(3): 513-522, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871306
18.
Get Outta Here! Addition of Mobilizing Agents to Conditioning Regimen Improves Donor Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome.
Biol Blood Marrow Transplant
; 24(7): 1309-1311, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29753160
19.
Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide.
Ther Adv Hematol
; 14: 20406207231174304, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37250913
20.
Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial.
Open Forum Infect Dis
; 10(11): ofad518, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37953814